share_log

HC Wainwright & Co. Maintains Buy on Aadi Bioscience, Lowers Price Target to $36

HC Wainwright & Co. Maintains Buy on Aadi Bioscience, Lowers Price Target to $36

HC Wainwright & Co.维持对Aadi Bioscience的买入,将目标股价下调至36美元
Benzinga ·  2023/11/13 18:15

HC Wainwright & Co. analyst Robert Burns maintains Aadi Bioscience (NASDAQ:AADI) with a Buy and lowers the price target from $45 to $36.

HC Wainwright & Co. 分析师罗伯特·伯恩斯维持Aadi Bioscience(纳斯达克股票代码:AADI)的买入,并将目标股价从45美元下调至36美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发